LOS ANGELES, CA–(Marketwired – Oct 15, 2013) – Fresh Start Private Management, Inc. (OTCQB: CEYY) released its revenue projections for 2014. Now that monies have begun to be paid out from a major insurance carrier in California that constitutes the overwhelming majority of the clinic’s patients, the company is in a better position to project future revenue from both California clinics. Now that reimbursement is occurring, marketing has been resumed. With the San Francisco area clinic opening soon, Fresh Start Private projects that those two clinics alone will result in approximately $3.6 million in revenue to Fresh Start Private Management, Inc. during fiscal 2014. This doesn’t include revenue expected from the future clinics in Nebraska and Arizona, as well as other possible locations in the US or abroad.

“These projections are conservative and realistic based on analysis of past marketing campaigns done by the clinic. It’s important for our shareholders to know that attracting patients is not a problem when marketing is done. Any stalls in business have been due to a cash flow back-up while we were waiting for the clinics to get reimbursed from insurance carriers. The company’s hands were tied as we patiently allowed them the time to negotiate the insurance process. Processing claims and actually getting paid for claims are not one in the same. Having any insurance pay is a huge milestone in our industry,” stated Kent Emry, CEO of Fresh Start Private. “It’s exciting to imagine what our revenue projections will look like once we have 10 clinics online.”

About Fresh Start Private

Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two components used by alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component developed by Fresh Start Private is a one on one counseling program specifically tailored for the treatment of alcoholism. For more information on CEYY, visit www.freshstartprivate.com

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Contact:
Investor Relations
Maximum Performance Advisors, Inc.
858-381-4677